DocGo Inc. (DCGO)
NASDAQ: DCGO · Real-Time Price · USD
2.685
+0.045 (1.70%)
Apr 1, 2025, 3:43 PM EDT - Market open

Company Description

DocGo Inc. provides mobile health and medical transportation services in the United States and the United Kingdom.

The company offers transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services.

It also provides mobile health services through its platform that are performed at home, offices, and other locations; event services, including on-site healthcare support at sporting events and concerts; and total care management solutions comprising healthcare services and ancillary services, such as shelter.

DocGo Inc. was incorporated in 2015 and is headquartered in New York, New York.

DocGo Inc.
DocGo logo
Country United States
Founded 2015
Industry Medical Care Facilities
Sector Healthcare
Employees 4,407
CEO Lee Bienstock

Contact Details

Address:
685 Third Avenue, 9th Floor
New York, New York 10017
United States
Phone 844 443 6246
Website docgo.com

Stock Details

Ticker Symbol DCGO
Exchange NASDAQ
Stock Type Common Stock
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001822359
CUSIP Number 256086109
ISIN Number US2560861096
Employer ID 85-2515483
SIC Code 8000

Key Executives

Name Position
Dr. James Powell M.D. Chief Executive Officer of Clinical Practice Group and Member of Medical Advisory Board
Lee Bienstock Chief Executive Officer and Director
Norman Rosenberg Treasurer and Chief Financial Officer
Ely D. Tendler J.D. General Counsel, Secretary and Director
Stephen Sugrue Chief Compliance Officer
Andre Oberholzer CPA Executive Vice President of Strategy
Eiwe Lingefors Chief Information Officer
Mike Cole Vice President of Investor Relations
Rosemarie Milano Vice President of Human Resources

Latest SEC Filings

Date Type Title
Feb 28, 2025 S-8 Securities to be offered to employees in employee benefit plans
Feb 27, 2025 10-K Annual Report
Feb 27, 2025 8-K Current Report
Feb 13, 2025 SCHEDULE 13G/A Filing
Dec 20, 2024 8-K Current Report
Dec 17, 2024 144 Filing
Dec 16, 2024 144 Filing
Nov 29, 2024 SC 13D/A [Amend] General statement of acquisition of beneficial ownership
Nov 14, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals
Nov 7, 2024 10-Q Quarterly Report